These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 33104321
21. Effects of Bempedoic Acid in Acute Myocardial Infarction in Rats: No Cardioprotection and No Hidden Cardiotoxicity. Gergely TG, Brenner GB, Nagy RN, Sayour NV, Makkos A, Kovácsházi C, Tian H, Schulz R, Giricz Z, Görbe A, Ferdinandy P. Int J Mol Sci; 2023 Jan 13; 24(2):. PubMed ID: 36675100 [Abstract] [Full Text] [Related]
22. Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis. Perera K, Kam N, Ademi Z, Liew D, Zomer E. J Clin Lipidol; 2020 Jan 13; 14(6):772-783. PubMed ID: 32994152 [Abstract] [Full Text] [Related]
23. Lipid-lowering drugs. Med Lett Drugs Ther; 2022 Sep 19; 64(1659):145-152. PubMed ID: 36094548 [No Abstract] [Full Text] [Related]
28. Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials. Bays HE, Banach M, Catapano AL, Duell PB, Gotto AM, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Bloedon LT, Sasiela WJ, Ye Z, Ballantyne CM. J Clin Lipidol; 2020 Oct 19; 14(5):649-659.e6. PubMed ID: 32980290 [Abstract] [Full Text] [Related]
29. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. Banach M, Duell PB, Gotto AM, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Flaim J, Ye Z, Catapano AL. JAMA Cardiol; 2020 Oct 01; 5(10):1124-1135. PubMed ID: 32609313 [Abstract] [Full Text] [Related]
30. Bempedoic acid for the treatment of hypercholesterolemia. Yang J. Expert Rev Cardiovasc Ther; 2020 Jul 01; 18(7):373-380. PubMed ID: 32532162 [Abstract] [Full Text] [Related]
33. The Disposition and Metabolism of Bempedoic Acid, a Potent Inhibitor of ATP Citrate Lyase, in Healthy Human Subjects. Amore BM, Cramer C, MacDougall D, Emery MG. Drug Metab Dispos; 2023 May 01; 51(5):599-609. PubMed ID: 36878717 [Abstract] [Full Text] [Related]
34. Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial. Rubino J, MacDougall DE, Sterling LR, Kelly SE, McKenney JM, Lalwani ND. J Clin Lipidol; 2021 May 01; 15(4):593-601. PubMed ID: 34172394 [Abstract] [Full Text] [Related]
35. Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials. Zhao X, Ma X, Luo X, Shi Z, Deng Z, Jin Y, Xiao Z, Tan L, Liu P, Jiang S, Shu Y, Tang B, Qiu C. BMC Pharmacol Toxicol; 2020 Dec 04; 21(1):86. PubMed ID: 33276805 [Abstract] [Full Text] [Related]
37. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. Ballantyne CM, Banach M, Mancini GBJ, Lepor NE, Hanselman JC, Zhao X, Leiter LA. Atherosclerosis; 2018 Oct 04; 277():195-203. PubMed ID: 29910030 [Abstract] [Full Text] [Related]